HIV/AIDSSee more about HIV/AIDS
- state & global data
- view as grid
- view as list
This report provides an overview of the Department of Defense’s infectious disease efforts related to global health. The report looks at how DoD’s infectious disease activities are organized internally and coordinated with other U.S. government agencies and partners.
Implications of the Affordable Care Act for People With HIV Infection and the Ryan White HIV/AIDS Program: What Does the Future Hold?
There are numerous aspects of the Affordable Care Act that will be important for people with HIV in the U.S., — however, it is unlikely that these changes will address all the needs of people with HIV. The Ryan White HIV/AIDS Program will thus remain crucial for the provision of adequate health care to HIV-infected individuals, but it will need to change. Changes in the Ryan White Program’s role will depend largely on state decisions on Medicaid expansion and health care marketplaces. This article, published in the September/October issue of Topics in Antiviral Medicine, summarizes a presentation by Jennifer Kates of the Kaiser Family Foundation at the IAS–USA continuing education program held in New York, New York, in April 2013.
This press release announces a new consumer web portal to help people living with HIV navigate the Affordable Care Act (ACA). Specifically designed to address the needs of people with HIV, the Obamacare & You portal, funded by Gilead Sciences, Inc., is presented as part of Greater Than AIDS, a leading national public information initiative developed by the Kaiser Family Foundation together with the Black AIDS Institute.
U.S. Participation in International Health Treaties, Commitments, Partnerships, and Other Agreements
This report provides a comprehensive look at U.S. participation in 50 significant international treaties and agreements that directly or indirectly touch on health issues.
The U.S. role in such agreements has attracted renewed policy attention as a result of the Obama Administration’s Global Health Initiative, which includes a focus on stronger multilateral engagement on global health and development issues. Such international agreements help to establish political and legal commitments, formalize international relationships, and coordinate roles and responsibilities internationally.
This session will explore how policy makers and programme managers can work with the current state of knowledge and unanswered questions about what works in HIV prevention to develop strategic, combination prevention responses.
AIDS 2012: Comprehensive HIV Prevention for People Who Use Drugs: Ways Forward for Inclusion of Needle and Syringe Exchange Programmes
This session will address the potential impacts of restrictions on NSEPs, and propose ways forward for public health actors, community stakeholders, and drug users themselves to maintain and expand comprehensive services, including needle and syringe exchanges, despite the limitations in funding, restrictive political environments, and other barriers to the implementation of this preventive intervention.
This session will bring together some of these global leaders to discuss how, in their experience, public-private partnerships are an innovative way to bring together diverse organizations and target the same goal of efficient local programmes that, at the same time, translate into powerful advocacy tools at the global level.
This session will present examples of in-country ownership for developing strategies and solutions for achieving national HIV goals, drawing on the perspectives of government and business sectors.
Official Press Conference